KTYCF (Kits Eyecare) Research & Development: $0.0 Mil (TTM As of Mar. 2026)


KTYCF Kits Eyecare Ltd KTYCF
74 GF Score
Price $8.86
GF Value $10.23
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Kits Eyecare Research & Development?

Kits Eyecare KTYCF -1.37% 74 Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus rates KTYCF with a GF Score™ of 74/100 and a GF Value™ of $10.23 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Kits Eyecare's Research & Development for the three months ended in Mar. 2026 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.0 Mil.

Kits Eyecare  (OTCPK:KTYCF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Kits Eyecare Research & Development Related Terms

Kits Eyecare Research & Development Historical Data

* Premium members only.

The historical data trend for Kits Eyecare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kits Eyecare Research & Development Chart

Kits Eyecare Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Kits Eyecare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
KTYCF
74GF Score
Kits Eyecare Ltd KTYCF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kits Eyecare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
Kits Eyecare (KTYCF) has a Research & Development of $0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Kits Eyecare and its competitors.
Is Kits Eyecare's Research & Development too high?
Kits Eyecare's current Research & Development is $0.0 Mil. Overall, Kits Eyecare has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kits Eyecare's Research & Development compare to CASY and WSM?
Kits Eyecare's Research & Development of $0.0 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Retail - Cyclical company?
A good Research & Development depends on the Retail - Cyclical industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Kits Eyecare and its competitors. Kits Eyecare's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kits Eyecare stock overvalued right now?
Based on GuruFocus' analysis, Kits Eyecare (KTYCF) is currently considered Modestly Undervalued. The stock's GF Value™ is $10.23, compared to a current price of $8.86 — trading 13.4% below its estimated fair value. The current Research & Development is $0.0 Mil. Kits Eyecare's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Kits Eyecare (KTYCF), the current Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kits Eyecare (KTYCF) Overvalued in 2026?

Based on GuruFocus' analysis, Kits Eyecare stock appears to be undervalued. The current stock price of $8.86 is trading 13.4% below its estimated GF Value™ of $10.23. GuruFocus considers Kits Eyecare to be Modestly Undervalued.

Key valuation signals for KTYCF:

  • Research & Development: $0.0 Mil
  • GF Value™: $10.23 vs. price of $8.86 (13.4% below fair value)
  • GF Score™: 74/100 with 1 warning sign

No single metric tells the full story. See the KTYCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kits Eyecare Business Description

Other Exchanges 0P3:GermanyKITS:Canada
Address 510 Seymour Street, Suite 1020, Vancouver, BC, CAN, V6B 3J5
Kits Eyecare Ltd is a vertically integrated, digitally native eyecare platform that offers its customers access to a vast selection of the highest quality contact lenses and eyeglasses, including its exclusive KITS-designed products, and a suite of online vision tools. It operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. The company's contact lens partners include Alcon, Bausch & Lomb, CooperVision, and Johnson & Johnson, and its glasses partners include Gucci, Oakley, Prive Revaux, Ray-Ban and Tom Ford. Its geographic locations are the United States; and Canada and Other which generates the majority of its revenue from the United States.
74GF Score

Get the complete analysis for KTYCF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.86
Price
$10.23
GF Value